Prior Extrapulmonary Malignancy and Outcomes After Lung Cancer Resection.

Authors

Yoshihiro Ishikawa, Naoko Shigeta, Daiji Nemoto, Yoshiyuki Yasuura, Toru Aoyama, Madoka Toyoda, Yui Kaburaki, Tetsuya Isaka, Akitomo Kikuchi, Yohei Kameda, Kazuki Yamanaka, Daisuke Noma, Atsuo Gorai, Yoshiyuki Mishina, Kohei Ando, Shinya Iitsuka, Noritake Kikunishi, Hiroyasu Koga, Hiroyuki Adachi, Tetsukan Woo

Published in

Anticancer research. Volume 46. Issue 10. Pages 5541-5551.

Abstract

With the aging population, thoracic surgeons increasingly encounter patients with primary lung cancer who have a history of prior extrapulmonary malignancy (PEM). We investigated whether PEM independently compromises survival after curative-intent lung cancer resection and whether any difference is explained by impaired cancer control or competing mortality.
We retrospectively analyzed 1,857 consecutive lung cancer resections performed in 2017-2018 at 12 Yokohama City University-affiliated institutions. After exclusion of 74 patients with prior lung cancer only, 1,783 patients remained: 505 in the PEM group and 1,278 in the no prior extrapulmonary malignancy (NPEM) group. Overall survival (OS), recurrence-free survival (RFS), inverse probability of treatment weighting (IPTW)-adjusted outcomes, and Fine-Gray competing-risk analyses were evaluated.
Compared with the NPEM group, the PEM group was older and included higher proportions of men, ever-smokers, patients diagnosed during surveillance for other diseases, and patients treated with limited resection. Unadjusted 5-year OS was 80.43% in the PEM group and 81.42% in the NPEM group (p=0.092), whereas 5-year RFS was 68.76% and 68.52%, respectively (p=0.983). PEM was not independently associated with OS [hazard ratio (HR)=1.046, 95% confidence interval (CI)=0.825-1.326, p=0.712] or RFS (HR=0.970, 95%CI=0.798-1.178, p=0.756). IPTW-adjusted analyses were concordant. Fine-Gray models showed no significant association between PEM and lung cancer-related death or non-lung-cancer death.
PEM did not independently worsen postoperative cancer control or survival after lung cancer resection. Curative-intent surgery should therefore be considered according to the biology and operability of the current lung cancer rather than prior cancer history alone.

PMID:
42823163
Bibliographic data and abstract were imported from PubMed on 02 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.